George Hamilos

1.1k total citations
20 papers, 829 citations indexed

About

George Hamilos is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, George Hamilos has authored 20 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in George Hamilos's work include Antifungal resistance and susceptibility (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). George Hamilos is often cited by papers focused on Antifungal resistance and susceptibility (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). George Hamilos collaborates with scholars based in Greece, United States and Spain. George Hamilos's co-authors include Meletios Α. Dimopoulos, Eleni Efstathiou, John Souglakos, Ioannis Koliarakis, Ippokratis Messaritakis, Τaxiarchis Κonstantinos Νikolouzakis, John Tsiaoussis, Dimitra Gika, Christos Papadimitriou and Nikolaos Anagnostopoulos and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of Oncology and Supportive Care in Cancer.

In The Last Decade

George Hamilos

19 papers receiving 812 citations

Peers

George Hamilos
J Hermann Germany
George Hamilos
Citations per year, relative to George Hamilos George Hamilos (= 1×) peers J Hermann

Countries citing papers authored by George Hamilos

Since Specialization
Citations

This map shows the geographic impact of George Hamilos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Hamilos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Hamilos more than expected).

Fields of papers citing papers by George Hamilos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Hamilos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Hamilos. The network helps show where George Hamilos may publish in the future.

Co-authorship network of co-authors of George Hamilos

This figure shows the co-authorship network connecting the top 25 collaborators of George Hamilos. A scholar is included among the top collaborators of George Hamilos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Hamilos. George Hamilos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maraki, Sofia, et al.. (2024). Antimicrobial Resistance of Streptococcus pneumoniae Clinical Serotypes between 2017 and 2022 in Crete, Greece. Infection and Chemotherapy. 56(1). 73–73. 2 indexed citations
3.
Maraki, Sofia, Ioannis Neonakis, Dimitra Stafylaki, et al.. (2022). Exophiala dermatitidis Central Line-Associated Bloodstream Infection in a Child with Ewing’s Sarcoma: Case Report and Literature Review on Paediatric Infections. Mycopathologia. 187(5-6). 595–602. 4 indexed citations
4.
Maraki, Sofia, Dimitra Stafylaki, Spyridon Karageorgos, et al.. (2021). Antifungal activity of amniotic fluid against different Candida species. Revista Iberoamericana de Micología. 38(3). 148–150.
5.
Koliarakis, Ioannis, Ippokratis Messaritakis, Τaxiarchis Κonstantinos Νikolouzakis, et al.. (2019). Oral Bacteria and Intestinal Dysbiosis in Colorectal Cancer. International Journal of Molecular Sciences. 20(17). 4146–4146. 194 indexed citations
6.
Maraki, Sofia, et al.. (2019). Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis. Mycoses. 62(8). 692–697. 39 indexed citations
7.
Maraki, Sofia, Viktoria Eirini Mavromanolaki, Dimitra Stafylaki, George Hamilos, & George Samonis. (2018). The Evolving Epidemiology of Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Strains Isolated from Adults in Crete, Greece, 2009–2016. Infection and Chemotherapy. 50(4). 328–328. 13 indexed citations
8.
Maraki, Sofia, George Hamilos, Dimitra Dimopoulou, et al.. (2015). Study on the comparative activity of echinocandins on murine gut colonization byCandida albicans. Medical Mycology. 53(6). 597–602. 5 indexed citations
9.
Pongas, Georgios, George Hamilos, Kenneth Rolston, & Dimitrios P. Kontoyiannis. (2010). Formal adult infectious disease specialist consultations in the outpatient setting at a comprehensive cancer center (1998–2008): Diverse and impactful. Supportive Care in Cancer. 20(2). 261–265. 8 indexed citations
10.
Bamias, Aristotelis, Eleni Efstathiou, Lia A. Moulopoulos, et al.. (2005). The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy. Annals of Oncology. 16(2). 307–313. 54 indexed citations
11.
Dimopoulos, Meletios Α., George Hamilos, Athanasios Zomas, et al.. (2004). Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma. The Hematology Journal. 5(2). 112–117. 105 indexed citations
12.
Papadimitriou, Christos, S. Markaki, G. Vlachos, et al.. (2004). Hormonal Therapy with Letrozole for Relapsed Epithelial Ovarian Cancer. Oncology. 66(2). 112–117. 101 indexed citations
13.
Anagnostopoulos, Αchilles, Dimitra Gika, George Hamilos, et al.. (2004). Treatment of Relapsed/Refractory Multiple Myeloma with Thalidomide-based Regimens: Identification of Prognostic Factors. Leukemia & lymphoma. 45(11). 2275–2279. 10 indexed citations
14.
Dimopoulos, Meletios Α., George Hamilos, Eleni Efstathiou, et al.. (2003). Treatment of Waldenstrom's Macroglobulinemia with the Combination of Fludarabine and Cyclophosphamide. Leukemia & lymphoma. 44(6). 993–996. 33 indexed citations
15.
Dimopoulos, Meletios Α., C. Tsatalas, Athanassios Zomas, et al.. (2003). Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone. Seminars in Oncology. 30(2). 265–269. 39 indexed citations
16.
Dimopoulos, Meletios Α., George Hamilos, Konstantinos Zervas, et al.. (2003). Survival and prognostic factors after initiation of treatment in Waldenstrom’s macroglobulinemia. Annals of Oncology. 14(8). 1299–1305. 36 indexed citations
17.
Anagnostopoulos, Αchilles, et al.. (2003). Discordant Response or Progression in Patients with Myeloma Treated with Thalidomide-based Regimens. Leukemia & lymphoma. 45(1). 113–116. 15 indexed citations
18.
Economopoulos, Theofanis, George Fountzilas, Nicholas Pavlidis, et al.. (2003). Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma. The Hematology Journal. 4(2). 110–115. 10 indexed citations
19.
Dimopoulos, Meletios Α., Constantinos Zervas, Athanasios Zomas, et al.. (2002). Extended Rituximab Therapy for Previously Untreated Patients with Waldenström's Macroglobulinemia. Clinical Lymphoma. 3(3). 163–166. 56 indexed citations
20.
Dimopoulos, Meletios Α. & George Hamilos. (2002). Solitary bone plasmacytoma and extramedullary plasmacytoma. Current Treatment Options in Oncology. 3(3). 255–259. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026